Abstract:Abstract Despite tremendous progress in diagnosis and treatments of nasopharyngeal carcinoma (NPC) has been established nowadays, distant metastasis remains the major cause of death.The underlying molecular mechanisms are largely unknown. In the present study,we investigated the roles in NPCs for an axis of candidate metastasis-related genes located at 17q11.2-q12, chemokine C-C motif ligand 2 (CCL2), and located at 3p21.31, chemokine C-C motif receptor 2 (CCR2). ELISA analyses of human serum from 50 cases with NPC and 50 cases without NPC revealed the mean serum CCL2 concentration of cases with NPC was significantly higher than cases without NPC (P<0.001).Higher expression levels of CCL2 and CCR2 were frequently detected in NPCs compared with normal nasopharyngeal epithelium samples by IHC analyses, and both ectopic expressions were significantly associated with NPC metastasis (P = 0.039, p = 0.016, respectively) and poor overall survival (P = 0.011, p = 0.004, respectively). Overexpressions of CCL2 and CCR2 were observed in human strong-metastatic NPC cell line S18 originated from CNE2 and 58F originated from SUNE1. Correspondingly, relatively lower expressions of CCL2 and CCR2 were detected in human weak-metastatic NPC cell line S26 originated from CNE2 and SUNE1 with weaker-metastatic ability compared to 58F. Functional studies demonstrated that upregulating the expressions of CCL2 and CCR2 respectively in S26 and SUNE1 could effectively promote cell migration and invasion in vitro, and enhance tumor distant metastasis in vivo of nude mice, which could be further raised in cells overexpressing CCR2 with exogenous CCL2 in the medium. When CCL2 and CCR2 were silenced by shRNAs respectively in S18 and 58F, decrease of cell migration and invasion was showed and significantly fewer metastases were observed. However, adding exogenous CCL2 to the medium culturing CCR2-silencing cells could not rescue their weaken ability of migration and invasion and metastasis. Mechanistic investigations suggested that, dual overexpressions of CCL2/CCR2 could remarkably activate extracellular signal-regulated kinase (ERK1/2) signaling pathway, which sequentially induced matrix metalloproteinase (MMP)2/9 transcriptional activation to facilitate tumor metastasis. Taken as a whole, CCL2-CCR2 axis signaling plays a pivotal role in NPC metastasis by activating ERK1/2 pathway via upregulating MMP2 and MMP9, and this finding may help to identify novel therapeutic targets for a better clinical management of NPC. Citation Format: Jing Yang, Xing Lv, Yanqun Xiang, Xiang Guo, Jina Chen, Xinyuan Guan. CCL2/CCR2 axis signaling promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2 pathway via upregulating MMP2 and MMP9. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2254. doi:10.1158/1538-7445.AM2015-2254

EGFR-PKM2 Signaling Promotes the Metastatic Potential of Nasopharyngeal Carcinoma Through Induction of FOSL1 and ANTXR2

As an Independent Unfavorable Prognostic Factor, IL-8 Promotes Metastasis of Nasopharyngeal Carcinoma Through Induction of Epithelial–mesenchymal Transition and Activation of AKT Signaling

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

Upregulation of PNCK Promotes Metastasis and Angiogenesis Via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma

c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.

Correlation of Epidermal Growth Factor Receptor Activation to Metastasis-free Survival of Nasopharyngeal Carcinoma Patients

LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis

Ccl2-Ccr2 Axis Promotes Metastasis of Nasopharyngeal Carcinoma by Activating Erk1/2-Mmp2/9 Pathway

Evaluation Of Epidermal Growth Factor Receptor (Egfr) In Nasopharyngeal Carcinoma And Lymph Node Metastases: Implications For Egfr Targeted Therapy

Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics

Metastasis of Nasopharyngeal Carcinoma: What We Know and Do Not Know

ADAM22 Acts as a Novel Predictive Biomarker for Unfavorable Prognosis and Facilitates Metastasis via PI3K/AKT Signaling Pathway in Nasopharyngeal Carcinoma

Abstract 2254: CCL2/CCR2 Axis Signaling Promotes Metastasis of Nasopharyngeal Carcinoma by Activating ERK1/2 Pathway Via Upregulating MMP2 and MMP9

CDC42-interacting Protein 4 Promotes Metastasis of Nasopharyngeal Carcinoma by Mediating Invadopodia Formation and Activating EGFR Signaling

The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways

High NEK2 Confers to Poor Prognosis and Contributes to Cisplatin-Based Chemotherapy Resistance in Nasopharyngeal Carcinoma.

FGF-2 Signaling in Nasopharyngeal Carcinoma Modulates Pericyte-Macrophage Crosstalk and Metastasis.

Epidermal Growth Factor Receptor Could Play a Prognostic Role to Predict the Outcome of Nasopharyngeal Carcinoma: A Meta-Analysis.

Abstract 118: EGFL6, a Potential Novel Ligand of EGFR, Play Roles in Nasopharyngeal Cacinoma Metastasis Through Establishing Invasive and Long-Distant Metastatic Niche by Paracrine and Autocrine

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

LncRNA EPB41L4A-AS2 Represses Nasopharyngeal Carcinoma Metastasis by Binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm